Apogee Therapeutics, Inc.
corporate_fare Company Profile
Apogee Therapeutics, Inc. (NASDAQ:APGE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 37 items for APGE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-03, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 19 rated 8 or above. Recent SEC coverage for APGE spans 8-K, 10-Q, DEFA14A, DEFM14A.
Recent high-impact activity:
- AbbVie Completes $10.9B Acquisition of Apogee; APGE to Delist September 4
- Apogee Stockholders Overwhelmingly Approve $10.9B AbbVie Acquisition; All Directors to Resign at Close
- Q2 Report Confirms AbbVie Merger Progress, Strong Cash Position, Positive Clinical Data
- Apogee Q2 2026: $1.3B Cash, Pipeline Advances Ahead of AbbVie Vote
- Key regulatory hurdles cleared for Apogee's merger with AbbVie, with HSR, German, and Austrian approvals secured ahead of the August 11 vote
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$255.84M
Diluted EPS
-$4.22
Op. Cash Flow
-$227.45M
Free Cash Flow
-$232.6M
Operating Income
-$285.6M
Cash & Equivalents
$131.55M
Shares Outstanding
68.4M sh
Source: 10-K · filed 2026-03-02 · accession 0001974640-26-000002
feed APGE - Latest Insights
APGE
Sep 03, 2026, 8:53 AM EDT
APGE
Aug 11, 2026, 4:00 PM EDT
APGE
Aug 10, 2026, 7:52 AM EDT
APGE
Aug 10, 2026, 7:19 AM EDT
APGE
Aug 06, 2026, 6:31 AM EDT
APGE
Aug 03, 2026, 5:10 PM EDT
APGE
Jul 13, 2026, 5:15 PM EDT
APGE
Jul 02, 2026, 5:23 PM EDT
APGE
Jun 23, 2026, 5:00 PM EDT
APGE
Jun 23, 2026, 3:13 AM EDT
APGE
Jun 22, 2026, 5:10 PM EDT
APGE
Jun 22, 2026, 7:46 AM EDT
APGE
Jun 22, 2026, 7:45 AM EDT
APGE
Jun 22, 2026, 7:22 AM EDT
APGE
Jun 22, 2026, 5:55 AM EDT
APGE
May 27, 2026, 6:40 AM EDT
APGE
May 27, 2026, 6:37 AM EDT
APGE
May 27, 2026, 6:30 AM EDT
APGE
May 11, 2026, 7:20 AM EDT
APGE
May 11, 2026, 7:10 AM EDT